Cardiovascular Echocardiography Market is expected to reach US$ 200.00 billion by 2030

3D Echocardiogram Segment to Lead Cardiovascular Echocardiography Market Based on Technology During 2022–2030

According to our new research study on “Cardiovascular Echocardiography Market Forecast to 2030 – Global Analysis – by Type, Technology, End User, and Geography,” the market was valued at US$ 143.72 billion in 2022 and is projected to reach US$ 200.00 billion by 2030; it is expected to register a CAGR of 4.2% from 2022 to 2030. Cardiovascular echocardiography is a medical imaging technique that uses sound waves to create two or three-dimensional ultrasound images of the heart. Key factors driving the market growth include the rising burden of cardiovascular diseases and the advantages of echocardiographic devices over other cardiac diagnostic procedures. However, challenges associated with the use of echocardiography devices hinder the cardiovascular echocardiography growth of the market.

Cardiovascular Echocardiography Market Analysis Based on Segmental Evaluation:

By type, the market is categorized into transthoracic echocardiography, transesophageal echocardiography, stress echocardiography, and fetal echocardiography. The transthoracic echocardiography segment held a significant cardiovascular echocardiography market share in 2022 and is estimated to register the highest CAGR during the forecast period.

Cardiovascular Echocardiography Market, by Region, 2022(%)

To get sample Copy of the report, along with the TOC, Statistics, and Tables please visit @ https://www.theinsightpartners.com/brochure/TIPHE100000964

Source: The Insight Partners Analysis

Based on technology, the market is segmented into 2D echocardiogram, 3D echocardiogram, and Doppler. The 3D echocardiogram segment held a significant cardiovascular echocardiography market share in 2022 and is estimated to register the highest CAGR during 2022–2030. The 3D echocardiogram captures three-dimensional images of the heart structure. It is used to improve image quality and reader confidence to assess the structure and functionality. The real-time images provide a more accurate assessment of heart functioning using measurements taken while the heart is beating. The 3D echocardiography shows enhanced views of the heart’s anatomy and can be utilized to determine the proper treatment plan for a person with heart disease. Over the past two decades, advancements in computer and transducer technologies have allowed the development of 3D echocardiography, which offers significant additional clinical information to traditional 2D echocardiography.

In contrast to 2D echocardiography, 3D echocardiography has many advantages, such as enhanced visualization of complex shapes and spatial relations between cardiac structures; better quantitation of cardiac volumes, mass, and function; improved display and assessment of valve dysfunction; and reduced time for image acquisition, owing to which the market for the segment positively influencing the overall cardiovascular echocardiography market size.

The scope of the cardiovascular echocardiography market report entails North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. Asia Pacific is likely to register the highest CAGR in the market from 2022 to 2030. The rising geriatric population, growing prevalence of heart diseases, rise in awareness about heart diseases, and technological development of innovative cardiovascular echocardiography products are projected to support the Asia Pacific cardiovascular echocardiography market growth during the forecast period. China and Japan are the major contributors to the growth of the market in Asia Pacific.

CVD is China's leading cause of healthcare burden. The prevalence and incidence of this disease continue to rise across the country. As per the research article titled “Cardiovascular Disease Mortality and Potential Risk Factor in China: A Multi-Dimensional Assessment by a Grey Relational Approach,” published in April 2022, CVD is one of the major healthcare burdens in the country. Furthermore, 290 million people are suffering from cardiac disorders, stroke (13 million), coronary heart disease (11 million), rheumatic heart disease (2.5 million), heart failure (4.5 million), congenital heart disease (2 million), and pulmonary heart disease (5 million) in China.

According to the World Data 2022, ~29% of the population of Japan was aged 65 and above in 2021. As the geriatric population is more susceptible to chronic CVD, the rise in this population is expected to fuel the growth of the cardiovascular echocardiography market in Japan during the forecast period.

In addition, as per a study titled “In-Hospital Outcomes of Heart Failure Patients with Valvular Heart Disease: Insights from Real-World Claims Data,” published in May 2023, the number of patients with heart failure is rapidly increasing in Japan and is projected to surpass 1.3 million by 2030 as the population ages. Japanese patients aged 75–84 years and above >84 years have a higher all-cause mortality risk due to acute heart failure than younger patients. The burden of CVD has spurred significantly due to the high blood pressure, high prevalence of smoking, and unhealthy diet. Echocardiography is necessary to evaluate cardiac function, diagnose heart disease, and detect embolic sources of stroke in patients. Therefore, the growing number of patients with CVD in the region is likely to increase the demand for echocardiography, thereby positively affecting the cardiovascular echocardiography market growth.

Furthermore, in April 2023, Pie Medical Imaging, a cardiac imaging solutions provider, obtained NINSHO Medical Device Certification in Japan for CAAS Qardia, an echocardiography software platform. The certification allows the company to offer its CAAS Qardia solution to Japanese healthcare companies. The platform is created to provide efficient performance in evaluating diastolic function assessment, analyzing myocardial strain, and conducting stress-echo tests. It streamlines medical procedures by utilizing artificial intelligence-driven workflows to automate crucial clinical measurements and improve accessibility.

Moreover, incorporating AI and other advanced technologies in echocardiography devices is projected to bring new cardiovascular echocardiography market trends in the coming years.

Apex Heart and Vascular, Ultra-X Imaging, Metropolitan Heart Vascular Institute, Ultromics Limited, Corewell Health, Centinela Hospital Medical Center, Schoolcraft Memorial Hospital, University of Utah Health, Goshen Heart & Vascular Center, and Harefield Hospital are among the leading companies profiled in the cardiovascular echocardiography market report.

Based on type, the market is classified into transthoracic echocardiography, transesophageal echocardiography, stress echocardiography, and fetal echocardiography. In terms of technology, the market is classified into 2D echocardiogram, 3D echocardiogram, and Doppler. Based on end user, the market is categorized into hospitals, ambulatory surgery centers, and diagnostic labs. Geographically, the cardiovascular echocardiography market is categorized into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Contact Us
Contact Person: Content Team 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com